| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 99 |
| 1 | PREDNISONE | 94 |
| 2 | RITUXIMAB | 93 |
| 3 | METHOTREXATE SODIUM | 87 |
| 4 | ACETAMINOPHEN 500MG | 82 |
| 5 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 82 |
| 6 | PAIN RELIEVER | 82 |
| 7 | METHOTREXATE | 77 |
| 8 | DIPHENHYDRAMINE HYDROCHLORIDE | 72 |
| 9 | ASPIRIN | 70 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROCORTISONE VALERATE | 17 | 0.0271 |
| 1 | CALCIUM CHLORIDE DIHYDRATE | 1 | 0.0200 |
| 2 | TELISOTUZUMAB VEDOTIN | 1 | 0.0128 |
| 3 | MIRVETUXIMAB SORAVTANSINE | 12 | 0.0066 |
| 4 | PRILOCAINE HYDROCHLORIDE | 1 | 0.0062 |
| 5 | DELANDISTROGENE MOXEPARVOVEC-ROKL | 2 | 0.0054 |
| 6 | AMLODIPINE AND VALSARTAN | 1 | 0.0051 |
| 7 | SARECYCLINE HYDROCHLORIDE | 1 | 0.0050 |
| 8 | ONASEMNOGENE ABEPARVOVEC-XIOI | 10 | 0.0043 |
| 9 | SARGRAMOSTIM | 7 | 0.0040 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 207 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 164 |
| 2 | Proton Pump Inhibitor [EPC] | 130 |
| 3 | Platinum-based Drug [EPC] | 106 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 101 |
| 5 | Benzodiazepine [EPC] | 92 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 92 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 88 |
| 8 | Vitamin C [EPC] | 84 |
| 9 | Kinase Inhibitor [EPC] | 83 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 8 | 0.0043 |
| 1 | Carboxypeptidase [EPC] | 1 | 0.0028 |
| 2 | Peroxisome Proliferator-activated Receptor Agonist [EPC] | 2 | 0.0022 |
| 3 | Bile Acid [EPC] | 49 | 0.0021 |
| 4 | CD30-directed Immunoconjugate [EPC] | 19 | 0.0018 |
| 5 | CD3-directed Antibody [EPC] | 1 | 0.0014 |
| 6 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 7 | Thyroid Hormone Receptor beta Agonist [EPC] | 3 | 0.0013 |
| 8 | Neurokinin 3 Receptor Antagonist [EPC] | 3 | 0.0013 |
| 9 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 4 | 0.0012 |